Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 693.35

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Felix B who wrote (2502)	9/11/2018 9:20:56 PM
From: Miljenko Zuanic	of 3559

Who care! It is up to them. They have nice gain,...so they can sell at any time. REGN will continue to buy their lots, as long as price is "reasonable"! On other topic, REGN is pushing toward new Eylea combination for ischemic eye diseases: Apelin receptor antagonist (Abs): ncbi.nlm.nih.gov (competitor work) Also, patent application for combo with Aflibercept: appft.uspto.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next